Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279627 · ClinicalTrials.gov registry record
Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission
A clinical trial of Diabetes Mellitus, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT03279627: Completed study of Diabetes Mellitus, sponsored by University of Pittsburgh.
NCT03279627 is a study of Diabetes Mellitus that has completed, run by University of Pittsburgh. The registered enrollment target is 240 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03279627, a study of Diabetes Mellitus, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and explore the existing components of discharge planning provided to patients with insulin treated diabetes in the inpatient setting and to examine the contribution of glycemic excursions as well as comprehension of discharge instructions among patients with diabetes, in predicting hospital readmissions.
Primary Outcome
Participants will be asked to complete a questionnaire regarding their home diabetes medications including timing, adjusting, and medication names.
Conditions Studied
Interventions
- OTHER Diabetes Management Questionnaire
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2019-07-31 |
What the finished NCT03279627 record still lists
NCT03279627 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Management Questionnaire is the first listed.
NCT03279627 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03279627 about?
NCT03279627 is a clinical study titled "Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission". The purpose of this study is to identify and explore the existing components of discharge planning provided to patients with insulin treated diabetes in the inpatient setting and to examine the contribution of glycemic excursions as well as comprehension of discharge instructions among patients with...
What is the current status of trial NCT03279627?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2017-08-28. Estimated completion is 2019-07-31.
What conditions does trial NCT03279627 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT03279627?
The interventions under investigation include: Diabetes Management Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03279627?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03279627 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03279627's enrollment target sits among peer trials
240 82nd of 208 higher than 125 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI